MYUNGMOON Pharm co.,Ltd (017180.KS)
KRW 1860.0
(-0.59%)
KRW 1860.0
(-0.59%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -134.35 KRW | -157.73% |
| 2022 | 232.74 KRW | 215.64% |
| 2021 | -201.27 KRW | 78.77% |
| 2020 | -948.05 KRW | -13.94% |
| 2019 | -832.04 KRW | -2183.22% |
| 2018 | 39.94 KRW | -86.92% |
| 2017 | 305.36 KRW | 4.24% |
| 2016 | 292.95 KRW | 138.6% |
| 2015 | -758.86 KRW | -2238.24% |
| 2014 | 35.49 KRW | -26.37% |
| 2013 | 48.20 KRW | 108.35% |
| 2012 | -577.27 KRW | -324.0% |
| 2011 | 257.71 KRW | 36.85% |
| 2010 | 188.31 KRW | 3.84% |
| 2009 | 181.35 KRW | -44.54% |
| 2008 | 327.00 KRW | -38.27% |
| 2007 | 529.74 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -36.21 KRW | 69.89% |
| 2024 Q2 | -45.77 KRW | -26.4% |
| 2023 Q4 | -120.25 KRW | -330.39% |
| 2023 FY | - KRW | -157.73% |
| 2023 Q3 | -27.94 KRW | -589.88% |
| 2023 Q2 | -4.05 KRW | -136.0% |
| 2023 Q1 | 11.25 KRW | -91.79% |
| 2022 Q2 | 64.37 KRW | 121.97% |
| 2022 FY | - KRW | 215.64% |
| 2022 Q1 | 29.00 KRW | 112.12% |
| 2022 Q4 | 137.04 KRW | 4829.5% |
| 2022 Q3 | 2.78 KRW | -95.68% |
| 2021 Q1 | 18.00 KRW | 106.24% |
| 2021 Q2 | 18.00 KRW | 0.0% |
| 2021 Q4 | -239.28 KRW | -5882.0% |
| 2021 Q3 | -4.00 KRW | -122.22% |
| 2021 FY | - KRW | 78.77% |
| 2020 FY | - KRW | -13.94% |
| 2020 Q3 | -174.00 KRW | 55.04% |
| 2020 Q4 | -288.64 KRW | -65.89% |
| 2020 Q2 | -387.00 KRW | -83.91% |
| 2020 Q1 | -210.43 KRW | 57.42% |
| 2019 Q4 | -494.20 KRW | -774.69% |
| 2019 FY | - KRW | -2183.22% |
| 2019 Q3 | -56.50 KRW | 73.15% |
| 2019 Q2 | -210.43 KRW | -292.74% |
| 2019 Q1 | -53.58 KRW | -422.58% |
| 2018 Q3 | -7.79 KRW | -139.99% |
| 2018 FY | - KRW | -86.92% |
| 2018 Q1 | 23.38 KRW | -41.27% |
| 2018 Q2 | 19.48 KRW | -16.68% |
| 2018 Q4 | 16.61 KRW | 313.22% |
| 2017 FY | - KRW | 4.24% |
| 2017 Q2 | 224.25 KRW | 683.27% |
| 2017 Q3 | 13.36 KRW | -94.04% |
| 2017 Q1 | 28.63 KRW | -18.29% |
| 2017 Q4 | 39.81 KRW | 197.98% |
| 2016 Q1 | 109.28 KRW | 114.84% |
| 2016 Q4 | 35.04 KRW | -22.65% |
| 2016 Q3 | 45.30 KRW | -52.28% |
| 2016 Q2 | 94.92 KRW | -13.14% |
| 2016 FY | - KRW | 138.6% |
| 2015 Q3 | 54.93 KRW | 167.0% |
| 2015 Q1 | -24.51 KRW | -289.71% |
| 2015 Q4 | -736.34 KRW | -1440.51% |
| 2015 Q2 | -81.98 KRW | -234.48% |
| 2015 FY | - KRW | -2238.24% |
| 2014 Q3 | -4.90 KRW | -119.99% |
| 2014 Q2 | 24.51 KRW | 900.41% |
| 2014 Q4 | 12.92 KRW | 363.67% |
| 2014 Q1 | 2.45 KRW | 136.95% |
| 2014 FY | - KRW | -26.37% |
| 2013 Q3 | -19.82 KRW | -145.45% |
| 2013 FY | - KRW | 108.35% |
| 2013 Q2 | 43.61 KRW | 48.64% |
| 2013 Q4 | -6.63 KRW | 66.55% |
| 2013 Q1 | 29.34 KRW | 131.13% |
| 2012 Q1 | 42.03 KRW | 153.34% |
| 2012 FY | - KRW | -324.0% |
| 2012 Q2 | -405.99 KRW | -1065.95% |
| 2012 Q3 | -102.29 KRW | 74.8% |
| 2012 Q4 | -94.26 KRW | 7.85% |
| 2011 Q1 | 184.47 KRW | 315.68% |
| 2011 Q3 | 60.09 KRW | -51.83% |
| 2011 FY | - KRW | 36.85% |
| 2011 Q4 | -78.79 KRW | -231.12% |
| 2011 Q2 | 124.75 KRW | -32.37% |
| 2010 Q1 | 43.04 KRW | 332.15% |
| 2010 Q3 | 75.58 KRW | -48.3% |
| 2010 FY | - KRW | 3.84% |
| 2010 Q4 | -85.53 KRW | -213.16% |
| 2010 Q2 | 146.19 KRW | 239.66% |
| 2009 Q3 | 62.79 KRW | 7.06% |
| 2009 Q4 | -18.54 KRW | -129.53% |
| 2009 FY | - KRW | -44.54% |
| 2009 Q1 | 314.56 KRW | 207.1% |
| 2009 Q2 | 58.65 KRW | -81.35% |
| 2008 Q3 | -67.78 KRW | -141.75% |
| 2008 Q4 | 102.43 KRW | 251.12% |
| 2008 Q2 | 162.34 KRW | 0.0% |
| 2008 FY | - KRW | -38.27% |
| 2007 FY | - KRW | 0.0% |